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Abstract 
Review on GPC1, with data on DNA/RNA, on the 
protein encoded and where the gene is implicated. 
Identity 
Other names: glypican 
HGNC (Hugo): GPC1 
Location: 2q37.3 
DNA/RNA 
Description 
The gene spans 32381 pb of DNA, comprising 9 
exons. 
Transcription 
1676 bp open reading frame. 
Protein 
Description 
The glypican-1 gene codes for a protein of 558 
amino acids with a predicted molecular weight of 
62 kDa. It is a cell surface, lipid-raft-associated 
heparan sulfate proteoglycan (HSPG), composed of 
a glycosylphosphatidylinositol (GPI)-anchored core 
protein substituted with a three chains of heparan 
sulfate near its C-terminus. It shares, along with all 
other glypicans, an N-terminal secretory signal, 
heparan sulfate attachment sites, 14 evolutionary 
conserved cysteine residues and hydrophobic 
domain near the C-terminus for the addition of the 
glycosylphosphatidylinositol (GPI) anchor. Also, 
the glypican-1 core protein contains two N-
glycosylation sites at Asn79 & Asn116, which are 
found to be invariably occupied. The N-linked 
glycans at these sites affect Gpc-1 protein 
expression and heparan sulfate substitution. 
Nevertheless the protein is folded correctly even in 
the absence of N-linked glycans (Svensson et al., 
2011). Recently, the structure of C-terminally 
truncated human N-glycosylated Gpc-1 core protein 
was determined at 2.55 Å resolution (Svensson et 
al., 2012; Awad et al., 2013), which revealed a 
highly extended, cylindrical (dimensions 120 x 30 x 
30 Å), stable all-α-helical fold. Its structural 
similarity to the Dally-like protein from Drosophila 
(Kim et al., 2011) confirmed a conserved overall 
fold for the glypican family. The Gpc-1 structure 
consists of 14 α-helices (α1- α14) and three major 
loops (L1-L3). The extended helix α2 (83Å) 
traverses the whole protein, carrying two N-linked 
glycans close to its ends. The Gpc-1 structure 
revealed the complete arrangement of the 14 Cys 
residues conserved across the glypican family, in 7 
disulfide bonds, 6 of them located near the 
molecule N terminus at a region termed "Cys-rich 
lobe". This lobe is followed by a region forms the 
heart of the structure called the "central lobe". This 
lobe is stabilized by evolutionary conserved 
hydrophobic centers. The last region of the Gpc-1 
molecule is termed the "protease site lobe" because 
of the presence of a protease site in this part. No 
additional electron density was observed in the 
electron density maps from crystals of non-
truncated glypican-1 containing the HS attachment 
region near the C-terminus, which suggests that this 
part is highly disordered. This extended long C 
terminus (50 residues) might thus give the core 
protein a freedom in its orientation when Gpc-1 is 
anchored to the cell membrane (Svensson et al., 
2012). 
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Crystal structure of the N-glycosylated human Gpc-1 core protein (PDB entry 4ACR). Cartoon diagram of Gpc-1 in which 
the body of the structure is coloured light blue, the N-terminal helix and loop in dark blue and the C-terminal helix in red. 
Important loops (L1:L3) and all of the α-helices (α1:α14) are labelled. The seven disulphide bonds common to all glypicans are 
indicated in yellow. The assignment of different lobes in the Gpc-1 structure (Svensson et al., 2011) is displayed on the bottom 
line. 
 
Expression 
GPC1 is expressed mainly in the central nervous 
system (CNS) and skeletal system during 
development but also in many other tissues in the 
adult. 
Localisation 
GPC1 is a cell surface HSPG that can be 
internalized via a caveolin-1 associated pathway. 
GPC1 undergoes a recycling from cell surface to 
endosomes and back to the cell surface via Golgi. 
During recycling, the HS chains of GPC1 are 
degraded by heparanase and further on by a novel 
copper, nitric oxide and vitamin C-dependent 
deaminative cleavage. New HS chains are 
synthesized on the stubs remaining on the core 
protein (Cheng et al., 2002; Fransson and Mani, 
2007). 
Function 
Many of the functions of GPC1 are dependent on 
the HS side chains, which are capable of binding 
and/or activating and/or transporting a variety of 
growth factors (FGF2), cytokines, enzymes, viral 
proteins, and polyamines. It is known that both the 
core protein and the HS chains of GPC1 are 
important for brain function, as knock-out of GPC1 
gene expression results in reduction of brain size by 
30% (Jen et al., 2009) and errors in HS metabolism 
result in neurodegeneration and mental retardation 
accompanied by accumulation of amyloid β in 
human brain (Ohmi et al., 2011). A role for GPC1 
in axonal guidance and regeneration via Slit has 
been proposed (Bloechlinger et al., 2004; Lau and 
Margolis, 2010). Several studies indicate 
involvement of Gpc1 in prion conversion and 
scrapie infection (Löfgren et al., 2008; Taylor et al., 
2009; Hooper, 2011). 
Homology 
GPC1 belongs to the glypican family. To date, six 
different glypicans have been identified in 
vertebrates (GPC1, GPC2, GPC3, GPC4, GPC5, 
and GPC6), two in Drosophila melanogaster (Dally 
and Dally-like protein), two in C. elegans (Gpn-1 
and Lon-2) and one in zebrafish (knypek). Based on 
sequence comparisons, vertebrate glypicans fall 
into two subfamilies: glypicans 1, 2, 4, 6 and 
glypicans 3 and 5, with approximately 25% amino 
acid identity between the groups. 
Implicated in 
Various cancers 
Note 
Many studies have shown that GPC1 is crucial for 
efficient cancer cell growth, metastasis, and 
angiogenesis of many human and mouse cancer cell 
types (Ding et al., 2005; Kayed et al., 2006; Aikawa 
et al., 2008; Whipple et al., 2012). GPC1 is up-
regulated in human cancer cells such as glioma, 
pancreatic and breast cancers and supports and 
maintains the mitogenic effect of several HS-
binding growth factors (Matsuda et al., 2001; 
Kayed et al., 2006; Su et al., 2006). 
Downregulation of GPC1 results in prolonged 
doubling times and decreased growth of cancer 
cells in vitro, as well as attenuated tumor growth, 
angiogenesis, and metastasis in vivo. 
Neurodegenerative diseases 
Note 
A number of studies indicate involvement of GPC1 
in the pathogenesis of several neurodegenerative 
diseases including Alzheimer's disease (van 
Horssen et al., 2001; Watanabe et al., 2004; Cappai 
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et al., 2005; O'Callaghan et al., 2008; Timmer et al., 
2009; Cheng et al., 2011), prion disease (Cheng et 
al., 2006; Löfgren et al., 2008; Taylor et al., 2009; 
Hooper, 2011), and Niemann-Pick type C1 disease 
(Mani et al., 2006). GPC1 has been localized to the 
amyloid plaques of Alzheimer's disease. Both nitric 
oxide- and heparanase-induced degraded GPC1 HS 
have found to be associated with amyloid deposits, 
including the toxic amyloid β peptide aggregates in 
brain of human Alzheimer's patients and transgenic 
Alzheimer's mice (Sandwall et al., 2010; Cheng et 
al., 2011). Further, it has been shown that the HS 
oligosaccharides released from GPC1 by Cu/NO-
vitamin C form conjugates with amyloid β peptides, 
thereby modulating and suppressing 
oligomerization of amyloid β and dissolving toxic 
amyloid β oligomers in hippocampal slices from 
Alzheimer's mice (Cheng et al., 2011). Other 
studies have shown that amyloid β toxicity is 
attenuated in cells overexpressing heparanase, 
suggesting that HS oligosaccharides generated by 
cleavage with heparanase could also have a 
protective effect (Sandwall et al., 2010; Zhang et 
al., 2012). 
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